Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies.
Mohamed Mohamed Adel El-SokkaryLizaveta GotinaMohammad M Al-SaneaAe Nim PaeRehab Mohammed ElbargisyPublished in: Infection and drug resistance (2020)
The performed study identified and characterized several antiviral drug resistance mutations of HCV genotype 4a and proposed a mechanism by which the T282S mutation may contribute to SOF and ribavirin resistance.